Please enable JS

YOU ARE

A SPONSOR / CRO

Success is when the time to access an innovative treatment is reduced.

Get more informations

Optimize patient recruitment for your clinical trials

By providing CT-SCOUT™ to your clinical sites you will both facilitate their contribution to your studies and get a better overview of the site recruitment activities for your studies. You can also further enlarge your patient reach by providing ToTem4me to referral sites, with no need to train them on your studies.

THE PATIENT JOURNEY

Telemedicine Technologies favors direct contact with patients (with the medical team via ct-scout) and (with an expert clinical trial coordinator via ToTem4me) to involve them wherever they are and empower them to make the decision to participate in a clinical trial.

Through a questionnaire based on a powerful and reliable algorithm, you can pre-select qualified patients for your trial.

A coordinator is made available to the patient following registration on ToTem4me to follow up with the patient before, during and after inclusion in a clinical trial. A notification is sent to the clinical research team once a pest has been detected on CT-SCOUT™.

Get more information

Looking for innovative digital solutions to optimize patient recruitment in IBD trials

Read the post

Testimonials

« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,

Prof Laurent Peyrin-Biroulet
President, GETAID and ECCO

« CT-SCOUT™ represents a true added value to clinical research. It takes only few minutes to operate and study information is updated very quickly »

Prof Stéphane Nancey
Hepato-gastroenterology department,
Lyon-Sud University Hospital

« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,

Prof Laurent Peyrin-Biroulet
President, GETAID and ECCO

LATEST NEWSOUR NEWS >

telemedecine technologies news

Telemedicine Technologies will be present at SantEXPO Paris – E41

May 22, 2023

Wednesday may 24 TELEMEDICINE TECHNOLOGIES will be present at SantExpo on the OVHcloud stand as a partner of the “Open Trusted Cloud” program. Our president Yoani Matsakis will be representing Telemedicine Technologies, and wil intervene next to Mathieu Godart, CTO and co-founder of SÊMEIA and Emmanuel MEYRIEUX, Client Security manager at OVHcloud. Throughout the day you […]

READ MORE
telemedecine technologies news

Pfizer’s maternal RSV vaccine appears to win over FDA ahead of advisory meeting

May 22, 2023

Fierce Biotech The FDA seems to be satisfied that Pfizer’s RSV vaccine is safe and effective for administration in pregnant women to protect infants from severe disease. The agency’s confidence was revealed in briefing documents filed ahead of an advisory committee meeting set for Thursday. The Vaccines and Related Biological Products Advisory Committee will consider […]

READ MORE
telemedecine technologies news

WHO Announces End to COVID-19 Public Health Emergency of International Concern—At least Provisionally

May 22, 2023

Trial Site News The World Health Organisation (WHO) decided Thursday May 4, 2023, to end the COVID-19 public health emergency of international concern (PHEIC). TrialSite cautions that this is a provisional (temporary) status while WHO considers its forward-looking options (2023-2025). Importantly, in “The COVID-19 Emergency is Over, Sort of,” TrialSite reports that in America some […]

READ MORE